Raymond James analyst Steven Seedhouse maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $10 to $14.
Delsta 9 Q1 Revenue Grows 35% YoY, What About Net Loss?
DELTA 9 CANNABIS INC. (TSX:DN) (OTCQB: DLTNF) released its financial results for the three-month period ending March 31, 2023, revealing net revenue of CA$16.9 million ($12.6 million) versus CA$12.5 million for the three-month period ending March 31, 2022, an increas
